Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -90.17% is 104% below its 5-year average of -44.24%, near the low end of its 5-year range (-90.17%–-21.18%).
10.13% below its 12-month average of -81.88%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -16.04%.
RETURN ON ASSETS (ROA)
-90.17%
RETURN ON ASSETS (ROA) AVG TTM
-81.88%
RETURN ON ASSETS (ROA) AVG 3Y
-55.65%
RETURN ON ASSETS (ROA) AVG 5Y
-44.24%
RETURN ON ASSETS (ROA) AVG 10Y
-72.72%
RETURN ON ASSETS (ROA) AVG 15Y
-72.48%
RETURN ON ASSETS (ROA) AVG 20Y
-60.60%
CURRENT VS TTM AVG
-10.13%
CURRENT VS 3Y AVG
-62.05%
CURRENT VS 5Y AVG
-103.83%
CURRENT VS 10Y AVG
-23.99%
CURRENT VS 15Y AVG
-24.41%
CURRENT VS 20Y AVG
-48.79%
SECTOR MEDIAN · HEALTHCARE
-31.88%
median of 840 covered companies
CURRENT VS SECTOR MEDIAN
-182.89%
vs the sector median at left
Avita Medical Inc.
Market Cap
$319.65M
Return on Assets (ROA)
-90.17%
TTM Avg
-81.88%
3Y Avg
-55.65%
5Y Avg
-44.24%
Market Cap
$320.59M
Return on Assets (ROA)
-39.85%
TTM Avg
-37.20%
3Y Avg
-38.95%
5Y Avg
-33.46%
Market Cap
$318.98M
Return on Assets (ROA)
53.28%
TTM Avg
-50.19%
3Y Avg
-57.97%
5Y Avg
-53.56%
Market Cap
$321.85M
Return on Assets (ROA)
-46.30%
TTM Avg
-31.23%
3Y Avg
-20.32%
5Y Avg
-24.57%
Market Cap
$321.48M
Return on Assets (ROA)
-70.63%
TTM Avg
-82.15%
3Y Avg
-59.06%
5Y Avg
-50.33%
Market Cap
$324.92M
Return on Assets (ROA)
-160.64%
TTM Avg
-128.90%
3Y Avg
-103.44%
5Y Avg
-103.44%
Market Cap
$314.56M
Return on Assets (ROA)
-28.22%
TTM Avg
-29.68%
3Y Avg
-31.08%
5Y Avg
-26.24%
Market Cap
$302.32M
Return on Assets (ROA)
-24.94%
TTM Avg
-31.51%
3Y Avg
-135.72%
5Y Avg
-152.11%
Market Cap
$301.90M
Return on Assets (ROA)
-96.57%
TTM Avg
-96.57%
3Y Avg
-96.57%
5Y Avg
-96.57%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avita Medical Inc. (RCEL) | $319.65M | -90.17% | -81.88% | -55.65% | -44.24% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $320.59M | -39.85% | -37.20% | -38.95% | -33.46% |
| Agenus Inc. (AGEN)vs › | $318.98M | 53.28% | -50.19% | -57.97% | -53.56% |
| Sanara MedTech Inc. (SMTI)vs › | $321.85M | -46.30% | -31.23% | -20.32% | -24.57% |
| Cabaletta Bio, Inc. (CABA)vs › | $321.48M | -70.63% | -82.15% | -59.06% | -50.33% |
| CapsoVision, Inc. (CV)vs › | $324.92M | -160.64% | -128.90% | -103.44% | -103.44% |
| C4 Therapeutics, Inc. (CCCC)vs › | $314.56M | -28.22% | -29.68% | -31.08% | -26.24% |
| Benitec Biopharma Inc. (BNTC)vs › | $302.32M | -24.94% | -31.51% | -135.72% | -152.11% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $301.90M | -96.57% | -96.57% | -96.57% | -96.57% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.27M | -28.27% | -117.81% | -109.90% | -91.03% |
ROA
-90.2%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -86.16% |
| 2024-12-31 | -77.59% |
| 2023-12-31 | -31.69% |
| 2022-12-31 | -27.14% |
| 2021-12-31 | -21.67% |
| 2021-06-30 | -21.18% |
| 2020-06-30 | -50.97% |
| 2019-06-30 | -139.25% |
| 2018-06-30 | -74.80% |
| 2017-06-30 | -150.12% |
| 2016-06-30 | -119.40% |
| 2015-06-30 | -144.52% |
| 2014-06-30 | -70.39% |
| 2013-06-30 | -62.69% |
| 2012-06-30 | -70.90% |
| 2011-06-30 | -11.16% |
| 2010-06-30 | -63.71% |
| 2009-06-30 | -52.17% |
| 2008-06-30 | -75.21% |
| 2007-06-30 | -106.10% |
| 2006-06-30 | -67.94% |
| 2005-06-30 | -49.16% |
| 2004-06-30 | -54.36% |
| 2002-12-31 | -18.04% |
| 2001-12-31 | -22.18% |
| 2000-12-31 | -28.35% |
| 1999-12-31 | -28.94% |
| 1998-12-31 | -50.08% |
| 1997-12-31 | -127.38% |
| 1996-12-31 | 3.67% |
